Innate Pharma S.A. ADR (NQ: IPHA )
2.160
+0.010
(+0.47%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about Innate Pharma S.A. ADR
![](https://cdn.benzinga.com/files/images/story/2022/12/12/logo_light__aee8bc3b73f91a54cfbc891f93cceb13.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20221210005009/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20221208005422/en/1245155/4/INNATEvertnoirDS.jpg)
From Innate Pharma SA
Via Business Wire
![](https://mms.businesswire.com/media/20221130005789/en/1245155/4/INNATEvertnoirDS.jpg)
From Innate Pharma SA
Via Business Wire
![](https://mms.businesswire.com/media/20221113005104/en/1245155/4/INNATEvertnoirDS.jpg)
Innate Pharma Reports Third Quarter Financial Results
November 14, 2022
From Innate Pharma SA
Via Business Wire
![](https://mms.businesswire.com/media/20221106005016/en/1245155/4/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20221103006229/en/1245155/4/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20221101005160/en/1245155/4/INNATEvertnoirDS.jpg)
Innate Pharma to Participate in Upcoming Investor Conferences
November 02, 2022
From Innate Pharma SA
Via Business Wire
![](https://mms.businesswire.com/media/20221019005744/en/1245155/4/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20220922005753/en/1245155/4/INNATEvertnoirDS.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/20/image22.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/19/image24.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17233.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/19/image_7.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8582.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220914005962/en/1245155/4/INNATEvertnoirDS.jpg)
Innate Pharma Reports First Half 2022 Financial Results and Business Update
September 15, 2022
From Innate Pharma SA
Via Business Wire
![](https://mms.businesswire.com/media/20220907005694/en/1245155/4/INNATEvertnoirDS.jpg)
Innate Pharma Announces Conference Call and Webcast for First Half 2022 Business Update
September 08, 2022
From Innate Pharma SA
Via Business Wire
![](https://mms.businesswire.com/media/20220904005030/en/1245155/4/INNATEvertnoirDS.jpg)
Innate Pharma to Present Lacutamab PTCL Phase 1b Design and ANKET™ Platform at ESMO 2022
September 05, 2022
From Innate Pharma SA
Via Business Wire
![](https://mms.businesswire.com/media/20220822005508/en/1245155/4/INNATEvertnoirDS.jpg)
Innate Pharma to Participate in Upcoming Investor Conferences
August 23, 2022
From Innate Pharma SA
Via Business Wire
![](https://mms.businesswire.com/media/20220807005007/en/1245155/4/INNATEvertnoirDS.jpg)
From Innate Pharma SA
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/08/01/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/02/image-revlon.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/01/image26.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/01/aapharma_5.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13723.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/01/image12.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220731005041/en/1245155/4/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20220727005690/en/1245155/4/INNATEvertnoirDS.jpg)
From Innate Pharma SA
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.